MEDTRONIC NAVIGATION, INC (LITTLETON) O-ARM IMAGING SYSTEM; IMAGE-INTENSIFIED FLUOROSCOPIC X-RAY SYSTEM, M
|
Back to Search Results |
|
Model Number UNK_OARM_SYS |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Headache (1880); Hemorrhage/Bleeding (1888); Dysphasia (2195); Dyskinesia (2363)
|
Event Date 01/10/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
G2: this event occurred in spain.H3, h6: no products have been returned to medtronic for analysis.Codes b17, c20, and d15 are applicable.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Citation: campins-romeu m, sastre-batalleri, conde-sard6n r, baviera-muiiozcr, morata-martfnez c, freirecalvarez e, et al.Combined stn and gpi stimulation in parkinson's disease: balancing the unbalanced.Rev neurol 2023; 77: 83-6.Doi: 10.33588/ rn.7703.2022250.Summary: introduction:.Subthalamic nucleus (stn) and globus pallidus internus (gpi) deep brain stimulation (dbs) are the main surgical approaches for advanced parkinson's disease.Stimulation is usually applied bilaterally in the same brain structure.However, when various motor symptoms concomitantly present in the same patient, simultaneous modulation of different brain structures may be a suitable alternative.Case report: we present a patient with advanced parkinson's disease with a combined dbs neurosurgery.Left stn dbs optimally controlled the off right hemibody symptomatology while left side troublesome dyskinesias were successfully relieved by right gpi stimulation.Discussion: combined stn/gpi stimulation can be considered a suitable approach when challenging motor symptomatology arises in advanced parkinson's disease patients.Reported event(s): this was a case study of a 50 year old woman.Post-operatively, the patient experienced a small hemorrhage, a mild headache, and left upper limb dysmetria.Twenty days later, the patient was experiencing choreo-dyskinetic movements and disabling left-side dyskinesia.
|
|
Search Alerts/Recalls
|
|
|